1. https://www.faa.gov/about/office_org/headquarters_offices/avs/offices/aam/ame/guide/pharm/dni_dnf/ (stan na dzień 28.06.2021); Huang CZ et al. Antihistamine effects and safety of fexofenadine: a systematic review and Meta-analysis of randomized controlled trials. BMC Pharmacol Toxicol. 2019 Nov 29;20(1):72

1. Huang CZ et al. Antihistamine effects and safety of fexofenadine: a systematic review and Meta-analysis of randomized controlled trials. BMC Pharmacol Toxicol. 2019 Nov 29;20(1):72

2. Hashiguchi K, Wakabayashi KI, Togawa M, Saito A, Okubo K. Therapeutic effect of bilastine in Japanese cedar pollinosis using an artificial exposure chamber (OHIO Chamber). Allergol Int. 2017 Jan;66(1):123-131.

3. Bousquet J., et al.The ARIA/EAACI criteria for antihistamines: an assessment of the efficacy, safety and pharmacology of desloratadine. Allergy. 2004; 59 Suppl 77: 4-16.

4. Pawliczak R., Steroidy donosowe - terapia nowoczesna, bezpieczna. Terapia 2015 nr 9, z2 (328): 35-39.